Update on Long-term Stimulant Medication Treatment of Attention-Deficit Hyperactivity Disorder

2014 ◽  
Vol 35 (7) ◽  
pp. 446-447 ◽  
Author(s):  
William J. Barbaresi
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Stimulant Medication ◽  
Medication Treatment ◽  
Hyperactivity Disorder

Long-Term Stimulant Medication Treatment of Attention-Deficit/Hyperactivity Disorder

2014 ◽  
Vol 35 (7) ◽  
pp. 448-457 ◽  
Author(s):  
William J. Barbaresi ◽  
Slavica K. Katusic ◽  
Robert C. Colligan ◽  
Amy L. Weaver ◽  
Cynthia L. Leibson ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Stimulant Medication ◽  
Medication Treatment ◽  
Hyperactivity Disorder

Long-Term Stimulant Medication Treatment of Attention-Deficit/Hyperactivity Disorder

2006 ◽  
Vol 27 (1) ◽  
pp. 1-10 ◽  
Author(s):  
WILLIAM J. BARBARESI ◽  
SLAVICA K. KATUSIC ◽  
ROBERT C. COLLIGAN ◽  
AMY L. WEAVER ◽  
CYNTHIA L. LEIBSON ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Stimulant Medication ◽  
Medication Treatment ◽  
Hyperactivity Disorder

Current Approaches to Management of Attention Deficit Hyperactivity Disorder

1996 ◽  
Vol 13 (1) ◽  
pp. 46-55 ◽  
Author(s):  
Frederick C. Jarman
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Stimulant Medication ◽  
Scientific Evidence ◽  
Behaviour Modification ◽  
Hyperactivity Disorder ◽  
School Based ◽  
Long Term Prognosis

AbstractThe last five years in Australia have been marked by an explosion in the diagnosis and treatment of Attention Deficit Hyperactivity Disorder (ADHD). The use of stimulant medication for ADHD has increased exponentially across all states, raising questions about the appropriate role of drug treatment and its relationship to other therapies in these children. Despite widespread consensus that multimodal therapy is the preferred option for intervention, many treatments advocated for ADHD lack scientific evidence to support their use. Because no two children with ADHD or their families are the same, an individualised approach to management is advocated that targets both the primary symptoms of the disorder, its cornorbid pathology, and the secondary problems that have developed. Evidence indicates that stimulant medication used in conjunction with parent training, family support, and school based behaviour modification offers the best prospects for improving the disturbing long-term prognosis in these children.

Stimulant medication in ADHD: what do children and their parents say?

2005 ◽  
Vol 22 (1) ◽  
pp. 5-9 ◽  
Author(s):  
Catherine McElearney ◽  
Carol Fitzpatrick ◽  
Niamh Farrell ◽  
Mary King ◽  
Bryan Lynch
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Side Effects ◽  
Attention Deficit ◽  
Stimulant Medication ◽  
Medication Compliance ◽  
Structured Interview ◽  
Hyperactivity Disorder ◽  
Study Population ◽  
Children’S Views

AbstractObjectives: The prescription of stimulant medication to children with attention deficit hyperactivity disorder remains topical. Few reports target children's views about taking long-term medication. The aim was to assess child and parent views of stimulant medication. To compare attitudes to medication between two groups of children, those with attention deficit hyperactivity disorder taking stimulant medication and those with epilepsy taking anti-epileptic medication.Method: Forty children (n = 40) with attention deficit hyperactivity disorder on stimulant medication, and 40 children (n = 40) with epilepsy on anti-epileptic medication formed the study population. A semi-structured interview was carried out with each child and parent. Each parent completed the Dosage and Side-effects Questionnaire and the Attitude to Medication Questionnaire. Each child completed the Attitude to Medication Questionnaire.Results: Sixty per cent of children (n = 24) with attention deficit hyperactivity disorder and 62.5% (n = 25) of those with epilepsy knew the name and purpose of their medication. Forty per cent (n = 16) of children in the stimulant group and 32.5% (n = 13) in the anti-epileptic group reported themselves as being non-compliant with medication. In both groups children reported positive aspects to taking medication. More children with epilepsy reported negative aspects. Only 32.5% (n = 13) of children with attention deficit hyperactivity disorder said that they would tell a friend about their medication, while 55% (n = 22) of the children with epilepsy indicated that they would do so. In both groups parents were better informed than their children were about the purpose of the medication. Parents of children with attention deficit hyperactivity disorder tended to be more positive about medication than their children and than the parents in the comparison group.Conclusions: The majority of children and their parents express positive views about the stimulant medication. Children's views about medication compliance and side-effects should be sought, as they may differ significantly from those of their parents. Where parents have noticed positive changes, but children have not, this information can be used therapeutically to help children feel more in control of their behaviour.

scholarly journals Attention-deficit/hyperactivity disorder medication and seizures

Neurology ◽  
2018 ◽  
Vol 90 (13) ◽  
pp. e1104-e1110 ◽  
Author(s):  
Kelsey K. Wiggs ◽  
Zheng Chang ◽  
Patrick D. Quinn ◽  
Kwan Hur ◽  
Robert Gibbons ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Medication Use ◽  
Adhd Medication ◽  
Medication Treatment ◽  
Hyperactivity Disorder ◽  
Increased Risk ◽  
History Of ◽  
Antiepileptic Medications

ObjectiveIndividuals with attention-deficit/hyperactivity disorder (ADHD) are at increased risk of seizures, but there is uncertainty about whether ADHD medication treatment increases risk among patients with and without preexisting seizures.MethodsWe followed a sample of 801,838 patients with ADHD who had prescribed drug claims from the Truven Health MarketScan Commercial Claims and Encounters databases to examine whether ADHD medication increases the likelihood of seizures among ADHD patients with and without a history of seizures. First, we assessed overall risk of seizures among patients with ADHD. Second, within-individual concurrent analyses assessed odds of seizure events during months when a patient with ADHD received ADHD medication compared with when the same individual did not, while adjusting for antiepileptic medications. Third, within-individual long-term analyses examined odds of seizure events in relation to the duration of months over the previous 2 years patients received medication.ResultsPatients with ADHD were at higher odds for any seizure compared with non-ADHD controls (odds ratio [OR] = 2.33, 95% confidence interval [CI] = 2.24–2.42 males; OR = 2.31, 95% CI = 2.22–2.42 females). In adjusted within-individual comparisons, ADHD medication was associated with lower odds of seizures among patients with (OR = 0.71, 95% CI = 0.60–0.85) and without (OR = 0.71, 95% CI = 0.62–0.82) prior seizures. Long-term within-individual comparisons suggested no evidence of an association between medication use and seizures among individuals with (OR = 0.87, 95% CI = 0.59–1.30) and without (OR = 1.01, 95% CI = 0.80–1.28) a seizure history.ConclusionsResults reaffirm that patients with ADHD are at higher risk of seizures. However, ADHD medication was associated with lower risk of seizures within individuals while they were dispensed medication, which is not consistent with the hypothesis that ADHD medication increases risk of seizures.

Sign in / Sign up

Export Citation Format

Share Document